Our Mission

Our Mission is to decrease the quantity and severity of infections that cause human suffering and death, through the creation and development of novel, targeted, antimicrobial therapies

Our Approach

Address the ever-growing threat of drug resistant infections using targeted or localized, as opposed to systemic administration.

Increase efficacy and lower the toxicity of antimicrobial agents by:

1.  Increasing the local concentrations and overcoming drug resistance.

2.  Lowering the systemic exposure and, as a result, lowering the toxicity of the drugs.

Armis Biopharma® products are developed for the treatment and prevention of localized, drug-resistant infections.